GENE ONLINE|News &
Opinion
Blog

ADCs
IPO
Drawing Millions in Investment, RemeGen is Ready to Bag 514m in IPO
2020-10-29
Startups
Investors Back Seattle-Based Startup’s Novel Immuno-Oncology Program Targeting Solid Tumors
2020-09-26
R&D
Merck Bets Big on Seattle Genetics for Two Oncology Drugs
2020-09-16
Funding
AstraZeneca, Daiichi Sankyo Ink $6 Billion Deal for Lung and Breast Cancer Treatments
2020-07-28
New Frontiers in Therapeutics
2020-07-25Partner
R&D Breast Cancer
Trodelvy Gives New Hope to Patients with Relapsing Breast Cancer
2020-07-09
BioJapan 2019 Kicks Off with Importances on New Bioeconomy Strategy
2019-10-10
ADCs
Weekly in Asia（0414-0420）
2019-04-26
Trials & Approvals
Roche’s breast cancer drug, Kadcyla succeeds phase III trial
2018-10-22
Startups
Cambridge startup, GO Therapeutics make $195 million deal with Roche
2018-10-05
1 2
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top